Trial NCT04236141

View at ClinicalTrials.gov 
Org. Study IDs: YO41543

Last trial update was posted on 2023-03-03

MeSH Interventions

Bendamustine Hydrochloride Polatuzumab vedotin Rituximab

MeSH Conditions

Lymphoma Lymphoma, Large B-Cell, Diffuse

Other Conditions

Diffuse, Large B-Cell, Lymphoma

Stopping Reasons

Sponsor's decision, no safety concerns

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID